49
Views
0
CrossRef citations to date
0
Altmetric
Research

Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone

&
Article: 13 | Received 14 Sep 2017, Accepted 29 Mar 2019, Published online: 28 Nov 2023

References

  • World Health Organisation [WHO]. The importance of pharmacovigilance. Geneva: World Health Organisation; 2002.
  • Strengthening Pharmaceutical Systems [SPS]. Supporting Pharmacovigilance in Developing Countries: The Systems Perspective. Submitted to the U.S. Agency for International Development by the SPS Program. Arlington, VA: Management Sciences for Health; 2009.
  • World Health Organisation [WHO] (2010). Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. [online]. Available at: http://www.who.int/hiv/pub/2010progressreport/report/en/index.html [Accessed 1 September 2016].
  • Global Fund [GF]. (2011). The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Report of the Market Dynamics and Commodities Ad-Hoc Committee to 23rd Board Meeting. [online]. Available at: http://www.theglobalfund.org/documents/board/23/BM23_09MDC_ [Accessed 1 September 2016].
  • Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ: Br Med J. 335(7618):462.
  • Strengthening Pharmaceutical Systems [SPS]. Safety of Medicines in Sub-Saharan Africa: Assessment of Pharmacovigilance Systems and their Performance. Arlington, VA: US Agency for international development by the strengthening pharmaceutical Systems (SPS) program; 2011.
  • System for Improved Access to Pharmaceuticals and Services [SIAPS]. Comparative analysis of pharmacovigilance systems in five Asian countries. Arlington, VA: Systems for improved access to pharmaceuticals and services. Management Sciences for Health; 2013.
  • Statistics Sierra Leone [SSL] (2016). Sierra Leone Housing and Population Census. Provisional result [online]. Available at: https://www.statistics.sl/ [Accessed 2 September 2016].
  • Government of Sierra Leone [GoSL]. The Sierra Leone Gazette (Extraordinary):Pharmacy Board of Sierra Leone. Freetown: Government of Sierra Leone; 2016.
  • Sierra Leone Medical and Dental Association [SLMDA] (2015). Sierra Leone Medical and Dental Association Annual Congress and Scientific meeting. Freetown: Sierra Leone medical and Dental Association.
  • Ministry of Health and Sanitation [MOHS]. National Medicines Policy. Freetown: Directorate of Drugs and Medical Supplies, Ministry of Health and Sanitation; 2012.
  • Pharmacy Board of Sierra Leone [PBSL] (2016). Guideline for marketing authorisation holders: requirements for qualified person for pharmacovigilance (QPPV) [online]. Available at: http://www.pharmacyboard.gov.sl/site/Downloads/Guidelines.aspx [Accessed 1st September 2016].
  • Kabore L, Millet P, Fofana S, Berdai D, Adam C, Haramburu F. Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso. Drug Saf. 36(5):349–58.
  • Bisson G, Gross R, Miller V, Weller I, Walker A. Monitoring of long-term toxicities of HIV treatments: an international perspective. AIDS. 17(17):2407–17.
  • Pharmacy Board of Sierra Leone [PBSL] (2015). Pharmacy Board of Sierra Leone Annual Report.